Alto Neuroscience

Alto Neuroscience(ANRO)

MOUNTAIN VIEW, CA
Biotechnology

Focus: AI-derived brain biomarkers for therapeutic matching

Alto Neuroscience is a life sciences company focused on AI-derived brain biomarkers for therapeutic matching.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 2
Clinical Trials (1)
NCT06391593PD, PK, and Safety of ALTO-203 in Patients With MDD
Phase 2
Phase 2
Clinical Trials (1)
NCT05118750ALTO-300 in Depression
Phase 2
Clinical Trials (1)
NCT06656416ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2
ALTO-300 PO Tablet
Major Depressive Disorder
Phase 2
Clinical Trials (1)
NCT05157945ALTO-300 in Depression (ALTO-300-004)
Phase 2
ALTO-100 PO Tablet
Major Depressive Disorder
Phase 2
Clinical Trials (1)
NCT05419869Pilot Decentralized Trial
Phase 2
ALTO-100 PO tablet
Major Depressive Disorder
Phase 2
Clinical Trials (1)
NCT05117632ALTO-100 in MDD and/or PTSD
Phase 2
Clinical Trials (1)
NCT05712187Phase 2b Study of ALTO-100 in MDD
Phase 2
Clinical Trials (1)
NCT05922878Study of ALTO-300 in MDD
Phase 2
Phase 2
Clinical Trials (1)
NCT06502964Study of ALTO-101 in Patients With Schizophrenia
Phase 2
Phase 4
Clinical Trials (1)
NCT04388202Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram
Phase 4
Phase 4
Clinical Trials (1)
NCT04388189Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 11 clinical trials
SEC Filings: 1 available

Financials (FY2024)

R&D Spend
$30M
Net Income
-$36M
Cash
$83M